nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—ABCB1—lung cancer	0.2	1	CbGaD
Levomilnacipran—CYP2C19—Gefitinib—lung cancer	0.0314	0.0609	CbGbCtD
Levomilnacipran—CYP2C19—Teniposide—lung cancer	0.0305	0.0591	CbGbCtD
Levomilnacipran—ABCB1—Topotecan—lung cancer	0.0277	0.0537	CbGbCtD
Levomilnacipran—ABCB1—Gefitinib—lung cancer	0.0254	0.0491	CbGbCtD
Levomilnacipran—CYP2D6—Gefitinib—lung cancer	0.0239	0.0463	CbGbCtD
Levomilnacipran—CYP2C8—Erlotinib—lung cancer	0.0222	0.0429	CbGbCtD
Levomilnacipran—CYP2C8—Paclitaxel—lung cancer	0.0203	0.0393	CbGbCtD
Levomilnacipran—ABCB1—Vinorelbine—lung cancer	0.0195	0.0379	CbGbCtD
Levomilnacipran—CYP2D6—Vinorelbine—lung cancer	0.0184	0.0357	CbGbCtD
Levomilnacipran—CYP3A4—Topotecan—lung cancer	0.0166	0.0322	CbGbCtD
Levomilnacipran—CYP2C8—Etoposide—lung cancer	0.016	0.031	CbGbCtD
Levomilnacipran—ABCB1—Crizotinib—lung cancer	0.0156	0.0301	CbGbCtD
Levomilnacipran—CYP3A4—Gefitinib—lung cancer	0.0152	0.0294	CbGbCtD
Levomilnacipran—ABCB1—Gemcitabine—lung cancer	0.0152	0.0294	CbGbCtD
Levomilnacipran—ABCB1—Erlotinib—lung cancer	0.015	0.0291	CbGbCtD
Levomilnacipran—CYP3A4—Teniposide—lung cancer	0.0147	0.0285	CbGbCtD
Levomilnacipran—CYP2D6—Erlotinib—lung cancer	0.0141	0.0274	CbGbCtD
Levomilnacipran—ABCB1—Paclitaxel—lung cancer	0.0137	0.0266	CbGbCtD
Levomilnacipran—ABCB1—Irinotecan—lung cancer	0.0135	0.0262	CbGbCtD
Levomilnacipran—ABCB1—Vinblastine—lung cancer	0.012	0.0233	CbGbCtD
Levomilnacipran—CYP3A4—Vinorelbine—lung cancer	0.0117	0.0227	CbGbCtD
Levomilnacipran—CYP2D6—Vinblastine—lung cancer	0.0114	0.022	CbGbCtD
Levomilnacipran—ABCB1—Cisplatin—lung cancer	0.011	0.0214	CbGbCtD
Levomilnacipran—ABCB1—Etoposide—lung cancer	0.0109	0.021	CbGbCtD
Levomilnacipran—ABCB1—Docetaxel—lung cancer	0.00993	0.0192	CbGbCtD
Levomilnacipran—CYP3A4—Crizotinib—lung cancer	0.00932	0.018	CbGbCtD
Levomilnacipran—CYP3A4—Erlotinib—lung cancer	0.00899	0.0174	CbGbCtD
Levomilnacipran—CYP3A4—Paclitaxel—lung cancer	0.00823	0.0159	CbGbCtD
Levomilnacipran—CYP3A4—Irinotecan—lung cancer	0.00812	0.0157	CbGbCtD
Levomilnacipran—ABCB1—Doxorubicin—lung cancer	0.0074	0.0143	CbGbCtD
Levomilnacipran—CYP3A4—Vinblastine—lung cancer	0.00722	0.014	CbGbCtD
Levomilnacipran—ABCB1—Methotrexate—lung cancer	0.00717	0.0139	CbGbCtD
Levomilnacipran—CYP2D6—Doxorubicin—lung cancer	0.00697	0.0135	CbGbCtD
Levomilnacipran—CYP3A4—Etoposide—lung cancer	0.0065	0.0126	CbGbCtD
Levomilnacipran—CYP3A4—Docetaxel—lung cancer	0.00595	0.0115	CbGbCtD
Levomilnacipran—CYP3A4—Doxorubicin—lung cancer	0.00443	0.00859	CbGbCtD
Levomilnacipran—Nervous system disorder—Paclitaxel—lung cancer	0.000132	0.000765	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Paclitaxel—lung cancer	0.000132	0.000763	CcSEcCtD
Levomilnacipran—Tachycardia—Paclitaxel—lung cancer	0.000131	0.000761	CcSEcCtD
Levomilnacipran—Breast disorder—Doxorubicin—lung cancer	0.000131	0.000758	CcSEcCtD
Levomilnacipran—Anorexia—Etoposide—lung cancer	0.000131	0.000758	CcSEcCtD
Levomilnacipran—Skin disorder—Paclitaxel—lung cancer	0.000131	0.000757	CcSEcCtD
Levomilnacipran—Abdominal pain—Irinotecan—lung cancer	0.00013	0.000756	CcSEcCtD
Levomilnacipran—Body temperature increased—Irinotecan—lung cancer	0.00013	0.000756	CcSEcCtD
Levomilnacipran—Decreased appetite—Cisplatin—lung cancer	0.00013	0.000754	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Paclitaxel—lung cancer	0.00013	0.000754	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Cisplatin—lung cancer	0.000129	0.000749	CcSEcCtD
Levomilnacipran—Anorexia—Paclitaxel—lung cancer	0.000128	0.000743	CcSEcCtD
Levomilnacipran—Hypotension—Etoposide—lung cancer	0.000128	0.000743	CcSEcCtD
Levomilnacipran—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000128	0.00074	CcSEcCtD
Levomilnacipran—Vomiting—Vinorelbine—lung cancer	0.000127	0.000737	CcSEcCtD
Levomilnacipran—Body temperature increased—Gemcitabine—lung cancer	0.000127	0.000736	CcSEcCtD
Levomilnacipran—Rash—Vinorelbine—lung cancer	0.000126	0.000731	CcSEcCtD
Levomilnacipran—Dermatitis—Vinorelbine—lung cancer	0.000126	0.00073	CcSEcCtD
Levomilnacipran—Abdominal distension—Doxorubicin—lung cancer	0.000126	0.00073	CcSEcCtD
Levomilnacipran—Hypotension—Paclitaxel—lung cancer	0.000126	0.000728	CcSEcCtD
Levomilnacipran—Headache—Vinorelbine—lung cancer	0.000125	0.000726	CcSEcCtD
Levomilnacipran—Syncope—Docetaxel—lung cancer	0.000125	0.000726	CcSEcCtD
Levomilnacipran—Leukopenia—Docetaxel—lung cancer	0.000125	0.000725	CcSEcCtD
Levomilnacipran—Palpitations—Docetaxel—lung cancer	0.000123	0.000716	CcSEcCtD
Levomilnacipran—Paraesthesia—Etoposide—lung cancer	0.000123	0.000714	CcSEcCtD
Levomilnacipran—Haematuria—Methotrexate—lung cancer	0.000123	0.000712	CcSEcCtD
Levomilnacipran—Loss of consciousness—Docetaxel—lung cancer	0.000123	0.000712	CcSEcCtD
Levomilnacipran—Dyspnoea—Etoposide—lung cancer	0.000122	0.000709	CcSEcCtD
Levomilnacipran—Somnolence—Etoposide—lung cancer	0.000122	0.000707	CcSEcCtD
Levomilnacipran—Angina pectoris—Doxorubicin—lung cancer	0.000122	0.000706	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Methotrexate—lung cancer	0.000122	0.000706	CcSEcCtD
Levomilnacipran—Insomnia—Paclitaxel—lung cancer	0.000122	0.000705	CcSEcCtD
Levomilnacipran—Hypersensitivity—Irinotecan—lung cancer	0.000122	0.000704	CcSEcCtD
Levomilnacipran—Convulsion—Docetaxel—lung cancer	0.000121	0.000702	CcSEcCtD
Levomilnacipran—Paraesthesia—Paclitaxel—lung cancer	0.000121	0.0007	CcSEcCtD
Levomilnacipran—Hypertension—Docetaxel—lung cancer	0.000121	0.000699	CcSEcCtD
Levomilnacipran—Dyspnoea—Paclitaxel—lung cancer	0.00012	0.000695	CcSEcCtD
Levomilnacipran—Somnolence—Paclitaxel—lung cancer	0.00012	0.000693	CcSEcCtD
Levomilnacipran—Decreased appetite—Etoposide—lung cancer	0.000119	0.000691	CcSEcCtD
Levomilnacipran—Chest pain—Docetaxel—lung cancer	0.000119	0.000689	CcSEcCtD
Levomilnacipran—Nausea—Vinorelbine—lung cancer	0.000119	0.000688	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Etoposide—lung cancer	0.000118	0.000686	CcSEcCtD
Levomilnacipran—Dyspepsia—Paclitaxel—lung cancer	0.000118	0.000686	CcSEcCtD
Levomilnacipran—Body temperature increased—Cisplatin—lung cancer	0.000118	0.000686	CcSEcCtD
Levomilnacipran—Asthenia—Irinotecan—lung cancer	0.000118	0.000686	CcSEcCtD
Levomilnacipran—Fatigue—Etoposide—lung cancer	0.000118	0.000686	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000118	0.000685	CcSEcCtD
Levomilnacipran—Constipation—Etoposide—lung cancer	0.000117	0.00068	CcSEcCtD
Levomilnacipran—Dysuria—Doxorubicin—lung cancer	0.000117	0.000678	CcSEcCtD
Levomilnacipran—Neutropenia—Doxorubicin—lung cancer	0.000117	0.000678	CcSEcCtD
Levomilnacipran—Decreased appetite—Paclitaxel—lung cancer	0.000117	0.000678	CcSEcCtD
Levomilnacipran—Dry mouth—Docetaxel—lung cancer	0.000116	0.000674	CcSEcCtD
Levomilnacipran—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000116	0.000674	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000116	0.000673	CcSEcCtD
Levomilnacipran—Fatigue—Paclitaxel—lung cancer	0.000116	0.000672	CcSEcCtD
Levomilnacipran—Hepatitis—Methotrexate—lung cancer	0.000116	0.00067	CcSEcCtD
Levomilnacipran—Pollakiuria—Doxorubicin—lung cancer	0.000116	0.00067	CcSEcCtD
Levomilnacipran—Asthenia—Gemcitabine—lung cancer	0.000115	0.000668	CcSEcCtD
Levomilnacipran—Constipation—Paclitaxel—lung cancer	0.000115	0.000667	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Methotrexate—lung cancer	0.000114	0.000662	CcSEcCtD
Levomilnacipran—Pruritus—Gemcitabine—lung cancer	0.000114	0.000659	CcSEcCtD
Levomilnacipran—Urethral disorder—Methotrexate—lung cancer	0.000113	0.000657	CcSEcCtD
Levomilnacipran—Infection—Docetaxel—lung cancer	0.000113	0.000656	CcSEcCtD
Levomilnacipran—Weight decreased—Doxorubicin—lung cancer	0.000113	0.000656	CcSEcCtD
Levomilnacipran—Diarrhoea—Irinotecan—lung cancer	0.000113	0.000654	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Etoposide—lung cancer	0.000112	0.00065	CcSEcCtD
Levomilnacipran—Shock—Docetaxel—lung cancer	0.000112	0.00065	CcSEcCtD
Levomilnacipran—Nervous system disorder—Docetaxel—lung cancer	0.000112	0.000648	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Docetaxel—lung cancer	0.000112	0.000647	CcSEcCtD
Levomilnacipran—Tachycardia—Docetaxel—lung cancer	0.000111	0.000645	CcSEcCtD
Levomilnacipran—Skin disorder—Docetaxel—lung cancer	0.000111	0.000642	CcSEcCtD
Levomilnacipran—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000111	0.000641	CcSEcCtD
Levomilnacipran—Hypersensitivity—Cisplatin—lung cancer	0.00011	0.000639	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Paclitaxel—lung cancer	0.00011	0.000638	CcSEcCtD
Levomilnacipran—Diarrhoea—Gemcitabine—lung cancer	0.00011	0.000637	CcSEcCtD
Levomilnacipran—Erythema multiforme—Methotrexate—lung cancer	0.000109	0.000634	CcSEcCtD
Levomilnacipran—Dizziness—Irinotecan—lung cancer	0.000109	0.000632	CcSEcCtD
Levomilnacipran—Urticaria—Etoposide—lung cancer	0.000109	0.000632	CcSEcCtD
Levomilnacipran—Anorexia—Docetaxel—lung cancer	0.000109	0.00063	CcSEcCtD
Levomilnacipran—Body temperature increased—Etoposide—lung cancer	0.000108	0.000629	CcSEcCtD
Levomilnacipran—Abdominal pain—Etoposide—lung cancer	0.000108	0.000629	CcSEcCtD
Levomilnacipran—Urinary tract infection—Doxorubicin—lung cancer	0.000108	0.000629	CcSEcCtD
Levomilnacipran—Eye disorder—Methotrexate—lung cancer	0.000108	0.000626	CcSEcCtD
Levomilnacipran—Asthenia—Cisplatin—lung cancer	0.000107	0.000623	CcSEcCtD
Levomilnacipran—Cardiac disorder—Methotrexate—lung cancer	0.000107	0.000622	CcSEcCtD
Levomilnacipran—Urticaria—Paclitaxel—lung cancer	0.000107	0.000619	CcSEcCtD
Levomilnacipran—Hypotension—Docetaxel—lung cancer	0.000107	0.000617	CcSEcCtD
Levomilnacipran—Haematuria—Doxorubicin—lung cancer	0.000106	0.000617	CcSEcCtD
Levomilnacipran—Abdominal pain—Paclitaxel—lung cancer	0.000106	0.000616	CcSEcCtD
Levomilnacipran—Body temperature increased—Paclitaxel—lung cancer	0.000106	0.000616	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Doxorubicin—lung cancer	0.000106	0.000612	CcSEcCtD
Levomilnacipran—Angiopathy—Methotrexate—lung cancer	0.000105	0.000608	CcSEcCtD
Levomilnacipran—Vomiting—Irinotecan—lung cancer	0.000105	0.000608	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Methotrexate—lung cancer	0.000104	0.000604	CcSEcCtD
Levomilnacipran—Rash—Irinotecan—lung cancer	0.000104	0.000603	CcSEcCtD
Levomilnacipran—Dermatitis—Irinotecan—lung cancer	0.000104	0.000602	CcSEcCtD
Levomilnacipran—Chills—Methotrexate—lung cancer	0.000104	0.000602	CcSEcCtD
Levomilnacipran—Headache—Irinotecan—lung cancer	0.000103	0.000599	CcSEcCtD
Levomilnacipran—Insomnia—Docetaxel—lung cancer	0.000103	0.000598	CcSEcCtD
Levomilnacipran—Diarrhoea—Cisplatin—lung cancer	0.000102	0.000594	CcSEcCtD
Levomilnacipran—Paraesthesia—Docetaxel—lung cancer	0.000102	0.000593	CcSEcCtD
Levomilnacipran—Vomiting—Gemcitabine—lung cancer	0.000102	0.000592	CcSEcCtD
Levomilnacipran—Dyspnoea—Docetaxel—lung cancer	0.000102	0.000589	CcSEcCtD
Levomilnacipran—Somnolence—Docetaxel—lung cancer	0.000101	0.000587	CcSEcCtD
Levomilnacipran—Mental disorder—Methotrexate—lung cancer	0.000101	0.000587	CcSEcCtD
Levomilnacipran—Rash—Gemcitabine—lung cancer	0.000101	0.000587	CcSEcCtD
Levomilnacipran—Dermatitis—Gemcitabine—lung cancer	0.000101	0.000587	CcSEcCtD
Levomilnacipran—Hypersensitivity—Etoposide—lung cancer	0.000101	0.000586	CcSEcCtD
Levomilnacipran—Malnutrition—Methotrexate—lung cancer	0.000101	0.000584	CcSEcCtD
Levomilnacipran—Headache—Gemcitabine—lung cancer	0.000101	0.000583	CcSEcCtD
Levomilnacipran—Dyspepsia—Docetaxel—lung cancer	0.0001	0.000582	CcSEcCtD
Levomilnacipran—Hepatitis—Doxorubicin—lung cancer	0.0001	0.00058	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Doxorubicin—lung cancer	9.97e-05	0.000578	CcSEcCtD
Levomilnacipran—Decreased appetite—Docetaxel—lung cancer	9.91e-05	0.000574	CcSEcCtD
Levomilnacipran—Hypersensitivity—Paclitaxel—lung cancer	9.91e-05	0.000574	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Doxorubicin—lung cancer	9.89e-05	0.000573	CcSEcCtD
Levomilnacipran—Oedema peripheral—Doxorubicin—lung cancer	9.87e-05	0.000572	CcSEcCtD
Levomilnacipran—Dysgeusia—Methotrexate—lung cancer	9.86e-05	0.000571	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Docetaxel—lung cancer	9.84e-05	0.00057	CcSEcCtD
Levomilnacipran—Asthenia—Etoposide—lung cancer	9.84e-05	0.00057	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Doxorubicin—lung cancer	9.84e-05	0.00057	CcSEcCtD
Levomilnacipran—Fatigue—Docetaxel—lung cancer	9.83e-05	0.00057	CcSEcCtD
Levomilnacipran—Urethral disorder—Doxorubicin—lung cancer	9.82e-05	0.000569	CcSEcCtD
Levomilnacipran—Nausea—Irinotecan—lung cancer	9.8e-05	0.000568	CcSEcCtD
Levomilnacipran—Constipation—Docetaxel—lung cancer	9.75e-05	0.000565	CcSEcCtD
Levomilnacipran—Pruritus—Etoposide—lung cancer	9.71e-05	0.000563	CcSEcCtD
Levomilnacipran—Asthenia—Paclitaxel—lung cancer	9.65e-05	0.000559	CcSEcCtD
Levomilnacipran—Nausea—Gemcitabine—lung cancer	9.54e-05	0.000553	CcSEcCtD
Levomilnacipran—Vomiting—Cisplatin—lung cancer	9.52e-05	0.000552	CcSEcCtD
Levomilnacipran—Pruritus—Paclitaxel—lung cancer	9.52e-05	0.000552	CcSEcCtD
Levomilnacipran—Vision blurred—Methotrexate—lung cancer	9.49e-05	0.00055	CcSEcCtD
Levomilnacipran—Erythema multiforme—Doxorubicin—lung cancer	9.47e-05	0.000549	CcSEcCtD
Levomilnacipran—Rash—Cisplatin—lung cancer	9.44e-05	0.000547	CcSEcCtD
Levomilnacipran—Dermatitis—Cisplatin—lung cancer	9.43e-05	0.000547	CcSEcCtD
Levomilnacipran—Diarrhoea—Etoposide—lung cancer	9.39e-05	0.000544	CcSEcCtD
Levomilnacipran—Eye disorder—Doxorubicin—lung cancer	9.36e-05	0.000542	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Docetaxel—lung cancer	9.32e-05	0.00054	CcSEcCtD
Levomilnacipran—Cardiac disorder—Doxorubicin—lung cancer	9.3e-05	0.000539	CcSEcCtD
Levomilnacipran—Flushing—Doxorubicin—lung cancer	9.3e-05	0.000539	CcSEcCtD
Levomilnacipran—Diarrhoea—Paclitaxel—lung cancer	9.2e-05	0.000533	CcSEcCtD
Levomilnacipran—Angiopathy—Doxorubicin—lung cancer	9.09e-05	0.000527	CcSEcCtD
Levomilnacipran—Dizziness—Etoposide—lung cancer	9.07e-05	0.000526	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Doxorubicin—lung cancer	9.03e-05	0.000523	CcSEcCtD
Levomilnacipran—Body temperature increased—Docetaxel—lung cancer	9.01e-05	0.000522	CcSEcCtD
Levomilnacipran—Abdominal pain—Docetaxel—lung cancer	9.01e-05	0.000522	CcSEcCtD
Levomilnacipran—Leukopenia—Methotrexate—lung cancer	9.01e-05	0.000522	CcSEcCtD
Levomilnacipran—Chills—Doxorubicin—lung cancer	8.99e-05	0.000521	CcSEcCtD
Levomilnacipran—Dizziness—Paclitaxel—lung cancer	8.9e-05	0.000516	CcSEcCtD
Levomilnacipran—Nausea—Cisplatin—lung cancer	8.9e-05	0.000516	CcSEcCtD
Levomilnacipran—Mental disorder—Doxorubicin—lung cancer	8.77e-05	0.000509	CcSEcCtD
Levomilnacipran—Convulsion—Methotrexate—lung cancer	8.72e-05	0.000506	CcSEcCtD
Levomilnacipran—Vomiting—Etoposide—lung cancer	8.72e-05	0.000506	CcSEcCtD
Levomilnacipran—Malnutrition—Doxorubicin—lung cancer	8.72e-05	0.000505	CcSEcCtD
Levomilnacipran—Rash—Etoposide—lung cancer	8.65e-05	0.000501	CcSEcCtD
Levomilnacipran—Dermatitis—Etoposide—lung cancer	8.64e-05	0.000501	CcSEcCtD
Levomilnacipran—Headache—Etoposide—lung cancer	8.59e-05	0.000498	CcSEcCtD
Levomilnacipran—Flatulence—Doxorubicin—lung cancer	8.59e-05	0.000498	CcSEcCtD
Levomilnacipran—Chest pain—Methotrexate—lung cancer	8.57e-05	0.000497	CcSEcCtD
Levomilnacipran—Tension—Doxorubicin—lung cancer	8.56e-05	0.000496	CcSEcCtD
Levomilnacipran—Vomiting—Paclitaxel—lung cancer	8.55e-05	0.000496	CcSEcCtD
Levomilnacipran—Dysgeusia—Doxorubicin—lung cancer	8.54e-05	0.000495	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	8.51e-05	0.000493	CcSEcCtD
Levomilnacipran—Rash—Paclitaxel—lung cancer	8.48e-05	0.000492	CcSEcCtD
Levomilnacipran—Dermatitis—Paclitaxel—lung cancer	8.47e-05	0.000491	CcSEcCtD
Levomilnacipran—Headache—Paclitaxel—lung cancer	8.43e-05	0.000488	CcSEcCtD
Levomilnacipran—Hypersensitivity—Docetaxel—lung cancer	8.4e-05	0.000487	CcSEcCtD
Levomilnacipran—Vision blurred—Doxorubicin—lung cancer	8.22e-05	0.000476	CcSEcCtD
Levomilnacipran—Asthenia—Docetaxel—lung cancer	8.18e-05	0.000474	CcSEcCtD
Levomilnacipran—Infection—Methotrexate—lung cancer	8.16e-05	0.000473	CcSEcCtD
Levomilnacipran—Nausea—Etoposide—lung cancer	8.15e-05	0.000472	CcSEcCtD
Levomilnacipran—Pruritus—Docetaxel—lung cancer	8.07e-05	0.000468	CcSEcCtD
Levomilnacipran—Nervous system disorder—Methotrexate—lung cancer	8.06e-05	0.000467	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Methotrexate—lung cancer	8.05e-05	0.000466	CcSEcCtD
Levomilnacipran—Agitation—Doxorubicin—lung cancer	8.01e-05	0.000464	CcSEcCtD
Levomilnacipran—Nausea—Paclitaxel—lung cancer	7.99e-05	0.000463	CcSEcCtD
Levomilnacipran—Skin disorder—Methotrexate—lung cancer	7.98e-05	0.000463	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Methotrexate—lung cancer	7.94e-05	0.00046	CcSEcCtD
Levomilnacipran—Anorexia—Methotrexate—lung cancer	7.83e-05	0.000454	CcSEcCtD
Levomilnacipran—Syncope—Doxorubicin—lung cancer	7.82e-05	0.000453	CcSEcCtD
Levomilnacipran—Leukopenia—Doxorubicin—lung cancer	7.8e-05	0.000452	CcSEcCtD
Levomilnacipran—Diarrhoea—Docetaxel—lung cancer	7.8e-05	0.000452	CcSEcCtD
Levomilnacipran—Palpitations—Doxorubicin—lung cancer	7.71e-05	0.000447	CcSEcCtD
Levomilnacipran—Hypotension—Methotrexate—lung cancer	7.68e-05	0.000445	CcSEcCtD
Levomilnacipran—Loss of consciousness—Doxorubicin—lung cancer	7.66e-05	0.000444	CcSEcCtD
Levomilnacipran—Convulsion—Doxorubicin—lung cancer	7.55e-05	0.000438	CcSEcCtD
Levomilnacipran—Dizziness—Docetaxel—lung cancer	7.54e-05	0.000437	CcSEcCtD
Levomilnacipran—Hypertension—Doxorubicin—lung cancer	7.53e-05	0.000436	CcSEcCtD
Levomilnacipran—Insomnia—Methotrexate—lung cancer	7.43e-05	0.000431	CcSEcCtD
Levomilnacipran—Chest pain—Doxorubicin—lung cancer	7.42e-05	0.00043	CcSEcCtD
Levomilnacipran—Anxiety—Doxorubicin—lung cancer	7.4e-05	0.000429	CcSEcCtD
Levomilnacipran—Paraesthesia—Methotrexate—lung cancer	7.38e-05	0.000428	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	7.37e-05	0.000427	CcSEcCtD
Levomilnacipran—Dyspnoea—Methotrexate—lung cancer	7.33e-05	0.000425	CcSEcCtD
Levomilnacipran—Somnolence—Methotrexate—lung cancer	7.31e-05	0.000423	CcSEcCtD
Levomilnacipran—Dry mouth—Doxorubicin—lung cancer	7.26e-05	0.000421	CcSEcCtD
Levomilnacipran—Vomiting—Docetaxel—lung cancer	7.25e-05	0.00042	CcSEcCtD
Levomilnacipran—Dyspepsia—Methotrexate—lung cancer	7.23e-05	0.000419	CcSEcCtD
Levomilnacipran—Rash—Docetaxel—lung cancer	7.19e-05	0.000417	CcSEcCtD
Levomilnacipran—Dermatitis—Docetaxel—lung cancer	7.18e-05	0.000416	CcSEcCtD
Levomilnacipran—Decreased appetite—Methotrexate—lung cancer	7.14e-05	0.000414	CcSEcCtD
Levomilnacipran—Headache—Docetaxel—lung cancer	7.14e-05	0.000414	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Methotrexate—lung cancer	7.09e-05	0.000411	CcSEcCtD
Levomilnacipran—Fatigue—Methotrexate—lung cancer	7.09e-05	0.000411	CcSEcCtD
Levomilnacipran—Infection—Doxorubicin—lung cancer	7.07e-05	0.00041	CcSEcCtD
Levomilnacipran—Shock—Doxorubicin—lung cancer	7e-05	0.000406	CcSEcCtD
Levomilnacipran—Nervous system disorder—Doxorubicin—lung cancer	6.98e-05	0.000404	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Doxorubicin—lung cancer	6.97e-05	0.000404	CcSEcCtD
Levomilnacipran—Tachycardia—Doxorubicin—lung cancer	6.95e-05	0.000402	CcSEcCtD
Levomilnacipran—Skin disorder—Doxorubicin—lung cancer	6.91e-05	0.000401	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Doxorubicin—lung cancer	6.88e-05	0.000399	CcSEcCtD
Levomilnacipran—Anorexia—Doxorubicin—lung cancer	6.78e-05	0.000393	CcSEcCtD
Levomilnacipran—Nausea—Docetaxel—lung cancer	6.77e-05	0.000393	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Methotrexate—lung cancer	6.72e-05	0.000389	CcSEcCtD
Levomilnacipran—Hypotension—Doxorubicin—lung cancer	6.65e-05	0.000385	CcSEcCtD
Levomilnacipran—Urticaria—Methotrexate—lung cancer	6.53e-05	0.000378	CcSEcCtD
Levomilnacipran—Abdominal pain—Methotrexate—lung cancer	6.5e-05	0.000377	CcSEcCtD
Levomilnacipran—Body temperature increased—Methotrexate—lung cancer	6.5e-05	0.000377	CcSEcCtD
Levomilnacipran—Insomnia—Doxorubicin—lung cancer	6.44e-05	0.000373	CcSEcCtD
Levomilnacipran—Paraesthesia—Doxorubicin—lung cancer	6.39e-05	0.00037	CcSEcCtD
Levomilnacipran—Dyspnoea—Doxorubicin—lung cancer	6.34e-05	0.000368	CcSEcCtD
Levomilnacipran—Somnolence—Doxorubicin—lung cancer	6.33e-05	0.000367	CcSEcCtD
Levomilnacipran—Dyspepsia—Doxorubicin—lung cancer	6.26e-05	0.000363	CcSEcCtD
Levomilnacipran—Decreased appetite—Doxorubicin—lung cancer	6.19e-05	0.000359	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Doxorubicin—lung cancer	6.14e-05	0.000356	CcSEcCtD
Levomilnacipran—Fatigue—Doxorubicin—lung cancer	6.14e-05	0.000356	CcSEcCtD
Levomilnacipran—Constipation—Doxorubicin—lung cancer	6.09e-05	0.000353	CcSEcCtD
Levomilnacipran—Hypersensitivity—Methotrexate—lung cancer	6.05e-05	0.000351	CcSEcCtD
Levomilnacipran—Asthenia—Methotrexate—lung cancer	5.9e-05	0.000342	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Doxorubicin—lung cancer	5.82e-05	0.000337	CcSEcCtD
Levomilnacipran—Pruritus—Methotrexate—lung cancer	5.81e-05	0.000337	CcSEcCtD
Levomilnacipran—Urticaria—Doxorubicin—lung cancer	5.65e-05	0.000328	CcSEcCtD
Levomilnacipran—Abdominal pain—Doxorubicin—lung cancer	5.63e-05	0.000326	CcSEcCtD
Levomilnacipran—Body temperature increased—Doxorubicin—lung cancer	5.63e-05	0.000326	CcSEcCtD
Levomilnacipran—Diarrhoea—Methotrexate—lung cancer	5.62e-05	0.000326	CcSEcCtD
Levomilnacipran—Dizziness—Methotrexate—lung cancer	5.43e-05	0.000315	CcSEcCtD
Levomilnacipran—Hypersensitivity—Doxorubicin—lung cancer	5.24e-05	0.000304	CcSEcCtD
Levomilnacipran—Vomiting—Methotrexate—lung cancer	5.23e-05	0.000303	CcSEcCtD
Levomilnacipran—Rash—Methotrexate—lung cancer	5.18e-05	0.0003	CcSEcCtD
Levomilnacipran—Dermatitis—Methotrexate—lung cancer	5.18e-05	0.0003	CcSEcCtD
Levomilnacipran—Headache—Methotrexate—lung cancer	5.15e-05	0.000298	CcSEcCtD
Levomilnacipran—Asthenia—Doxorubicin—lung cancer	5.11e-05	0.000296	CcSEcCtD
Levomilnacipran—Pruritus—Doxorubicin—lung cancer	5.03e-05	0.000292	CcSEcCtD
Levomilnacipran—Nausea—Methotrexate—lung cancer	4.88e-05	0.000283	CcSEcCtD
Levomilnacipran—Diarrhoea—Doxorubicin—lung cancer	4.87e-05	0.000282	CcSEcCtD
Levomilnacipran—Dizziness—Doxorubicin—lung cancer	4.71e-05	0.000273	CcSEcCtD
Levomilnacipran—Vomiting—Doxorubicin—lung cancer	4.52e-05	0.000262	CcSEcCtD
Levomilnacipran—Rash—Doxorubicin—lung cancer	4.49e-05	0.00026	CcSEcCtD
Levomilnacipran—Dermatitis—Doxorubicin—lung cancer	4.48e-05	0.00026	CcSEcCtD
Levomilnacipran—Headache—Doxorubicin—lung cancer	4.46e-05	0.000258	CcSEcCtD
Levomilnacipran—Nausea—Doxorubicin—lung cancer	4.23e-05	0.000245	CcSEcCtD
Levomilnacipran—CYP3A4—Metabolism—PLBD1—lung cancer	1.48e-05	0.000134	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	1.48e-05	0.000134	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PTEN—lung cancer	1.47e-05	0.000133	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.47e-05	0.000133	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—AKR1C1—lung cancer	1.47e-05	0.000132	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—RRM1—lung cancer	1.46e-05	0.000132	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GSTA3—lung cancer	1.46e-05	0.000132	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—B4GALT5—lung cancer	1.46e-05	0.000132	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GSTA4—lung cancer	1.45e-05	0.000131	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.43e-05	0.000129	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—UGT1A1—lung cancer	1.42e-05	0.000128	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.42e-05	0.000128	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GSTA4—lung cancer	1.42e-05	0.000128	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GSTA2—lung cancer	1.42e-05	0.000128	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—EP300—lung cancer	1.41e-05	0.000127	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.4e-05	0.000126	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GSTA2—lung cancer	1.38e-05	0.000125	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—B4GALT5—lung cancer	1.38e-05	0.000124	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GNG11—lung cancer	1.37e-05	0.000124	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GSTA1—lung cancer	1.37e-05	0.000123	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.37e-05	0.000123	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HSD17B10—lung cancer	1.36e-05	0.000122	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ABCC3—lung cancer	1.35e-05	0.000122	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GSTA4—lung cancer	1.34e-05	0.000121	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GSTA1—lung cancer	1.33e-05	0.00012	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.32e-05	0.000119	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ABCC3—lung cancer	1.32e-05	0.000119	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—AKR1C1—lung cancer	1.31e-05	0.000118	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALDOA—lung cancer	1.31e-05	0.000118	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GSTA2—lung cancer	1.3e-05	0.000118	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—AKR1C1—lung cancer	1.28e-05	0.000115	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—UGT1A1—lung cancer	1.27e-05	0.000115	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NCOA3—lung cancer	1.27e-05	0.000115	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CKB—lung cancer	1.26e-05	0.000114	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GSTA1—lung cancer	1.26e-05	0.000113	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.25e-05	0.000113	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ABCC3—lung cancer	1.24e-05	0.000112	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—UGT1A1—lung cancer	1.24e-05	0.000112	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ABCG2—lung cancer	1.24e-05	0.000111	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ADCY1—lung cancer	1.24e-05	0.000111	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GNG11—lung cancer	1.23e-05	0.000111	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.22e-05	0.00011	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.22e-05	0.00011	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ENO2—lung cancer	1.21e-05	0.000109	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—HPGDS—lung cancer	1.21e-05	0.000109	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—AKR1C1—lung cancer	1.2e-05	0.000109	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPP2R1B—lung cancer	1.2e-05	0.000109	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GNG11—lung cancer	1.2e-05	0.000108	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.19e-05	0.000107	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTM2—lung cancer	1.19e-05	0.000107	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CNDP2—lung cancer	1.19e-05	0.000107	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.18e-05	0.000106	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GSTT1—lung cancer	1.17e-05	0.000106	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—UGT1A1—lung cancer	1.17e-05	0.000105	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALDOA—lung cancer	1.17e-05	0.000105	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GCLC—lung cancer	1.16e-05	0.000105	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP2A6—lung cancer	1.16e-05	0.000105	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.16e-05	0.000104	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—MTMR3—lung cancer	1.15e-05	0.000104	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALDOA—lung cancer	1.14e-05	0.000103	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NCOA3—lung cancer	1.13e-05	0.000102	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	1.13e-05	0.000102	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GNG11—lung cancer	1.13e-05	0.000102	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PGAM1—lung cancer	1.12e-05	0.000101	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.11e-05	0.0001	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NCOA3—lung cancer	1.11e-05	9.98e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ADCY1—lung cancer	1.1e-05	9.94e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ABCG2—lung cancer	1.1e-05	9.94e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ENO1—lung cancer	1.1e-05	9.93e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.1e-05	9.89e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.08e-05	9.77e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ENO2—lung cancer	1.08e-05	9.75e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—HPGDS—lung cancer	1.08e-05	9.75e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ADCY1—lung cancer	1.08e-05	9.7e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ABCG2—lung cancer	1.08e-05	9.7e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPP2R1B—lung cancer	1.07e-05	9.69e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALDOA—lung cancer	1.07e-05	9.68e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP2A7—lung cancer	1.07e-05	9.68e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.06e-05	9.56e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ENO2—lung cancer	1.06e-05	9.52e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—HPGDS—lung cancer	1.06e-05	9.52e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SDC4—lung cancer	1.05e-05	9.47e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GSTT1—lung cancer	1.05e-05	9.46e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPP2R1B—lung cancer	1.05e-05	9.46e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NCOA3—lung cancer	1.04e-05	9.4e-05	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PIK3CA—lung cancer	1.04e-05	9.38e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GCLC—lung cancer	1.04e-05	9.35e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP2A6—lung cancer	1.04e-05	9.35e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.03e-05	9.31e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GSTT1—lung cancer	1.02e-05	9.23e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ABCG2—lung cancer	1.01e-05	9.14e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ADCY1—lung cancer	1.01e-05	9.14e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP2A6—lung cancer	1.01e-05	9.12e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GCLC—lung cancer	1.01e-05	9.12e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ENO2—lung cancer	9.94e-06	8.97e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—HPGDS—lung cancer	9.94e-06	8.97e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	9.93e-06	8.96e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPP2R1B—lung cancer	9.88e-06	8.91e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP2E1—lung cancer	9.87e-06	8.91e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ENO1—lung cancer	9.83e-06	8.86e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	9.79e-06	8.83e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NQO1—lung cancer	9.76e-06	8.81e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	9.66e-06	8.72e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GSTT1—lung cancer	9.64e-06	8.7e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ENO1—lung cancer	9.59e-06	8.65e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	9.58e-06	8.64e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—RRM1—lung cancer	9.56e-06	8.63e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTA3—lung cancer	9.56e-06	8.63e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.56e-06	8.62e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP2A6—lung cancer	9.53e-06	8.6e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GCLC—lung cancer	9.53e-06	8.6e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.47e-06	8.54e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ENO1—lung cancer	9.04e-06	8.15e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—B4GALT5—lung cancer	8.99e-06	8.11e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	8.97e-06	8.09e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP2E1—lung cancer	8.81e-06	7.95e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—STK11—lung cancer	8.8e-06	7.94e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTA4—lung cancer	8.75e-06	7.89e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NQO1—lung cancer	8.71e-06	7.86e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP2E1—lung cancer	8.6e-06	7.76e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.53e-06	7.7e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTA2—lung cancer	8.52e-06	7.69e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NQO1—lung cancer	8.51e-06	7.67e-05	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—AKT1—lung cancer	8.49e-06	7.66e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	8.46e-06	7.63e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.26e-06	7.45e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTA1—lung cancer	8.22e-06	7.42e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GSTP1—lung cancer	8.14e-06	7.34e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ABCC3—lung cancer	8.13e-06	7.33e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	8.11e-06	7.32e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP2E1—lung cancer	8.11e-06	7.31e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NQO1—lung cancer	8.02e-06	7.23e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CAT—lung cancer	7.92e-06	7.15e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.88e-06	7.11e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AKR1C1—lung cancer	7.88e-06	7.1e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—STK11—lung cancer	7.86e-06	7.08e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ABCB1—lung cancer	7.71e-06	6.95e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—STK11—lung cancer	7.67e-06	6.91e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—UGT1A1—lung cancer	7.65e-06	6.9e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—TYMS—lung cancer	7.57e-06	6.83e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GSTM1—lung cancer	7.48e-06	6.75e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.37e-06	6.65e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GNG11—lung cancer	7.37e-06	6.65e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GSTP1—lung cancer	7.27e-06	6.56e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—STK11—lung cancer	7.23e-06	6.52e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GSTP1—lung cancer	7.09e-06	6.4e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP1A1—lung cancer	7.09e-06	6.4e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CAT—lung cancer	7.07e-06	6.38e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ERCC2—lung cancer	7.04e-06	6.35e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.03e-06	6.34e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALDOA—lung cancer	7.02e-06	6.33e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CAT—lung cancer	6.9e-06	6.23e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ABCB1—lung cancer	6.88e-06	6.21e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NCOA3—lung cancer	6.82e-06	6.15e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—TYMS—lung cancer	6.76e-06	6.09e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GSTP1—lung cancer	6.69e-06	6.03e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GSTM1—lung cancer	6.68e-06	6.02e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ABCG2—lung cancer	6.63e-06	5.98e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ADCY1—lung cancer	6.63e-06	5.98e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—TYMS—lung cancer	6.6e-06	5.95e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GSTM1—lung cancer	6.52e-06	5.88e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CAT—lung cancer	6.51e-06	5.87e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ENO2—lung cancer	6.5e-06	5.86e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HPGDS—lung cancer	6.5e-06	5.86e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPP2R1B—lung cancer	6.46e-06	5.83e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP1A1—lung cancer	6.33e-06	5.71e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ABCB1—lung cancer	6.33e-06	5.71e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTT1—lung cancer	6.31e-06	5.69e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ERCC2—lung cancer	6.28e-06	5.66e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GCLC—lung cancer	6.23e-06	5.62e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP2A6—lung cancer	6.23e-06	5.62e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—TYMS—lung cancer	6.22e-06	5.61e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP1A1—lung cancer	6.18e-06	5.57e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GSTM1—lung cancer	6.14e-06	5.54e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ERCC2—lung cancer	6.13e-06	5.53e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—APOA1—lung cancer	6.09e-06	5.49e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ENO1—lung cancer	5.91e-06	5.33e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.83e-06	5.26e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP1A1—lung cancer	5.82e-06	5.25e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ERCC2—lung cancer	5.78e-06	5.21e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PIK3CG—lung cancer	5.56e-06	5.01e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—APOA1—lung cancer	5.43e-06	4.9e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—APOA1—lung cancer	5.3e-06	4.78e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP2E1—lung cancer	5.3e-06	4.78e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—POMC—lung cancer	5.29e-06	4.77e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NQO1—lung cancer	5.24e-06	4.73e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.2e-06	4.69e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CREBBP—lung cancer	5.15e-06	4.65e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—APOA1—lung cancer	5e-06	4.51e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PIK3CG—lung cancer	4.96e-06	4.47e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PIK3CD—lung cancer	4.88e-06	4.41e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PIK3CG—lung cancer	4.84e-06	4.37e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALB—lung cancer	4.82e-06	4.35e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—STK11—lung cancer	4.72e-06	4.26e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—POMC—lung cancer	4.72e-06	4.26e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—POMC—lung cancer	4.61e-06	4.16e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CREBBP—lung cancer	4.6e-06	4.15e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PIK3CG—lung cancer	4.56e-06	4.11e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CREBBP—lung cancer	4.49e-06	4.05e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTP1—lung cancer	4.37e-06	3.94e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PIK3CD—lung cancer	4.36e-06	3.93e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—POMC—lung cancer	4.34e-06	3.92e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALB—lung cancer	4.3e-06	3.88e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PIK3CB—lung cancer	4.26e-06	3.84e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PIK3CD—lung cancer	4.26e-06	3.84e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CAT—lung cancer	4.25e-06	3.84e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CREBBP—lung cancer	4.23e-06	3.81e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PTGS2—lung cancer	4.22e-06	3.8e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALB—lung cancer	4.2e-06	3.79e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ABCB1—lung cancer	4.14e-06	3.73e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—TYMS—lung cancer	4.06e-06	3.66e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTM1—lung cancer	4.02e-06	3.62e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PIK3CD—lung cancer	4.01e-06	3.62e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALB—lung cancer	3.96e-06	3.57e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP1A1—lung cancer	3.81e-06	3.43e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PIK3CB—lung cancer	3.8e-06	3.43e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ERCC2—lung cancer	3.78e-06	3.41e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PTGS2—lung cancer	3.77e-06	3.4e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PIK3CB—lung cancer	3.71e-06	3.35e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PTEN—lung cancer	3.68e-06	3.32e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PTGS2—lung cancer	3.68e-06	3.31e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—EP300—lung cancer	3.51e-06	3.16e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PIK3CB—lung cancer	3.5e-06	3.15e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PTGS2—lung cancer	3.46e-06	3.12e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PTEN—lung cancer	3.28e-06	2.96e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOA1—lung cancer	3.27e-06	2.95e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PTEN—lung cancer	3.21e-06	2.89e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—EP300—lung cancer	3.13e-06	2.82e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—EP300—lung cancer	3.06e-06	2.76e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PTEN—lung cancer	3.02e-06	2.72e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PIK3CG—lung cancer	2.98e-06	2.69e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—EP300—lung cancer	2.88e-06	2.6e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—POMC—lung cancer	2.84e-06	2.56e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CREBBP—lung cancer	2.77e-06	2.49e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PIK3CD—lung cancer	2.62e-06	2.36e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PIK3CA—lung cancer	2.6e-06	2.34e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALB—lung cancer	2.59e-06	2.33e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PIK3CA—lung cancer	2.32e-06	2.09e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PIK3CB—lung cancer	2.29e-06	2.06e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PTGS2—lung cancer	2.26e-06	2.04e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PIK3CA—lung cancer	2.26e-06	2.04e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PIK3CA—lung cancer	2.13e-06	1.92e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—AKT1—lung cancer	2.12e-06	1.91e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PTEN—lung cancer	1.97e-06	1.78e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—AKT1—lung cancer	1.89e-06	1.71e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—EP300—lung cancer	1.88e-06	1.7e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—AKT1—lung cancer	1.85e-06	1.67e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—AKT1—lung cancer	1.74e-06	1.57e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PIK3CA—lung cancer	1.39e-06	1.26e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AKT1—lung cancer	1.14e-06	1.03e-05	CbGpPWpGaD
